Cure Alzheimer's Fund Welcomes Stephanie Wasco as New Executive VP for Marketing and Communications

Cure Alzheimer's Fund Welcomes New Leadership

Cure Alzheimer's Fund (CureAlz), a renowned nonprofit organization dedicated to Alzheimer's research, has announced the appointment of Stephanie Wasco as its new Executive Vice President of Marketing and Communications. In this pivotal role, Wasco will be responsible for crafting and executing strategies that not only bolster the organization’s brand but also enhance communication efforts and engagement with donors and the public.

With a strong background in conveying complex scientific narratives, Wasco is set to elevate the organization's mission, which focuses on funding groundbreaking research aimed at preventing, slowing, or reversing Alzheimer's disease. CureAlz CEO Meg Smith expressed great enthusiasm about Wasco's arrival, noting her extensive experience across life sciences and nonprofit sectors.

“Stephanie brings deep experience communicating complex science and building trusted brands across the life sciences, biomedical research, and nonprofit sectors,” Smith stated. “Her ability to translate scientific discovery into compelling stories will help broaden awareness of our mission and the extraordinary progress being made through Alzheimer's research.”

Wasco herself expressed her excitement, stating, “I am honored to join CureAlz and help advance its mission to transform our understanding of Alzheimer's disease through bold, collaborative research. I look forward to supporting the remarkable researchers, donors, and the team who are making this progress possible.”

Before joining CureAlz, Wasco held significant roles, including Senior Vice President of Communications for advanced markets at Biocon Biologics, Chief Communications Officer at The Jackson Laboratory, and Vice President of Corporate Communications at PerkinElmer. These past experiences have equipped her with a wealth of knowledge about effective communication strategies in corporate, research, and nonprofit environments.

The Cure Alzheimer's Fund, established in 2004, has committed over $270 million to research efforts, focusing on emerging findings that promise the highest probability of breakthroughs in Alzheimer’s treatment and prevention. The organization has consistently received top ratings for its fiscal responsibility and transparency, praised for allowing 100% of donations to directly support research initiatives.

Through Wasco's leadership, CureAlz aims to strengthen its outreach and impact in the fight against Alzheimer's, further engaging the community and raising awareness about the ongoing research efforts and promising advances in understanding this complex disease. This new leadership marks a significant step forward in the organization’s commitment to finding effective solutions for those affected by Alzheimer's.

As the nonprofit landscape evolves, the fresh approach brought in by Wasco is expected to empower CureAlz in its efforts to transform understanding and treatment about Alzheimer’s disease, fostering deeper connections with stakeholders and promoting a culture of innovation within its research endeavors.

In conclusion, the leadership change at Cure Alzheimer's Fund signifies a renewed commitment to fighting Alzheimer’s disease through strategic marketing and communication, aiming for greater public engagement and support in its mission.

For more information about Cure Alzheimer's Fund and the groundbreaking research being funded, please visit CureAlz.org.